<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<key-projects><projects><title>Vaccine Database Initiative</title><description>This project tracks the conversion of vaccine legacy clinical trial data into a standardized format and stores it in a newly created database so that OBE staff and other CBER staff can evaluate new approaches to analysis of safety and efficacy across studies.</description><dictionary></dictionary><outcome></outcome><accomplishment>TBD</accomplishment><free-text></free-text><table><title></title><free-text-table></free-text-table><overall-status><briefing>COMPLETED</briefing><prior-briefing>ON TRACK</prior-briefing></overall-status><row><type></type><milestone-description>A. Phase 1: Confirm reproducibility for all studies</milestone-description><milestone-date>6/30/2011</milestone-date><milestone-status>Completed</milestone-status><milestone-completion-date>6/28/2011</milestone-completion-date></row><row><type></type><milestone-description>B. Phase 2: Evaluate and determine which datasets can be pooled and create a new, larger dataset</milestone-description><milestone-date>9/30/2011</milestone-date><milestone-status>Completed</milestone-status><milestone-completion-date>9/30/2011</milestone-completion-date></row><row><type></type><milestone-description>C. Phase 3:  Launch new exploratory studies on autoimmune conditions and detecting unexpected and rare adverse events</milestone-description><milestone-date>12/30/2011</milestone-date><milestone-status>Completed</milestone-status><milestone-completion-date>12/19/2011</milestone-completion-date></row><row><type></type><milestone-description>D. Phase 4:  Perform subgroup analysis by gender on combined data.</milestone-description><milestone-date>1/31/2012</milestone-date><milestone-status>Completed</milestone-status><milestone-completion-date>1/31/2012</milestone-completion-date></row><row><type></type><milestone-description>E. Assess how combining data from multiple studies can contribute to improved public health outcomes</milestone-description><milestone-date>3/30/2012</milestone-date><milestone-date>&lt;i&gt;(5/30/2012)&lt;/i&gt;</milestone-date><milestone-status>Completed</milestone-status><milestone-completion-date>5/30/2012</milestone-completion-date></row><footnotes><note></note></footnotes></table></projects><glossary><word><text>Molecular Epidemiology</text><definition>Molecular epidemiology is a branch of medical science that focuses on the contribution of potential genetic and environmental risk factors, identified at the molecular level, to the etiology, distribution and prevention of disease within families and across populations.</definition></word></glossary><related-links><link><url>http://www.fda.gov/AboutFDA/Transparency/track/ucm206350.htm</url><text>FDA-TRACK CBER Cross Program Support Offices Dashboard</text></link></related-links></key-projects>
    






